Prostate cancer trials recruiting in Florida

All Prostate cancer trials nationally

Cities in Florida

Recruiting trials in Florida

• A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
  NCT06925737 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · Florida: Jacksonville
• A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
  NCT07103018 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · Florida: Miami, Port Saint Lucie
• A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials
  NCT05655494 · Phase: Not specified · Ages: 18 Years to 100 Years · Sex: All (male and female) · Florida: Gainesville, Jacksonville, Miami
• A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
  NCT05932862 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Florida: Jacksonville, Orlando, Tampa
• A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
  NCT05914116 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Florida: Celebration, Margate, Orlando, Plantation
• A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
  NCT06785636 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: Male · Florida: Miami
• A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
  NCT07005154 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · Florida: Tampa
• A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
  NCT06879041 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · Florida: Miami, Tampa
• A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer
  NCT07365995 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · Florida: Fort Myers, St. Petersburg, West Palm Beach
• A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
  NCT04729114 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · Florida: Tampa
• A Single-Arm, Blinded, Fluorescent PSMA Histopathology Trial of AS1986NS
  NCT06906471 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 90 Years · Sex: Male · Florida: Miami
• A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer
  NCT05800665 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · Florida: Orlando
• A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
  NCT06778863 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Florida: Miami
• A Study of DB-1310 in Advanced/Metastatic Solid Tumors
  NCT05785741 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Florida: Coral Gables, Margate, Orlando, Plantation
• A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
  NCT06999187 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Florida: Orlando, Sarasota
• A Study of DS9051b in Participants With Advanced or Metastatic Adrenocortical Carcinoma and Metastatic Castration-resistant Prostate Cancer
  NCT07189403 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Florida: Sarasota
• A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
  NCT06842498 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · Florida: Aventura, Hialeah, Miami
• A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
  NCT06172478 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Florida: Kissimmee
• A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
  NCT07503808 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Florida: Sarasota
• A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer
  NCT07082920 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · Florida: Sarasota
• A Study of JNJ-98768111 in Participants With Advanced Prostate Cancer
  NCT07746713 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · Florida: Sarasota
• A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
  NCT06465069 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Florida: St. Petersburg
• A Study of LY4257496 in Participants With Cancer (OMNIRAY)
  NCT07114601 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Florida: Miami, Tampa
• A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
  NCT06952803 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · Florida: Hialeah, Jacksonville, Tallahassee, Tampa
• A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
  NCT06136650 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Florida: Fort Myers, Miami Beach, Pembroke Pines
• A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
  NCT06395519 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Florida: Jacksonville
• A Study of Pasritamig (JNJ-78278343) in Combination With JNJ-86974680 for Treatment of Prostate Cancer
  NCT07319871 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Florida: Sarasota
• A Study of Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate Cancer
  NCT05818683 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · Florida: Sarasota
• A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
  NCT07225946 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Florida: Orlando, Sarasota
• A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
  NCT07164443 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · Florida: Bay Pines, Fort Myers, Tampa
• A Study of SYNC-T Therapy SV-102 in Participants With Metastatic Castration-Resistant Prostate Cancer
  NCT06533644 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · Florida: Jacksonville, Miami, Tampa
• A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
  NCT04104776 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Florida: Tampa
• A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
  NCT07213674 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · Florida: Tampa
• A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer
  NCT07581184 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · Florida: Miami
• A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
  NCT06067841 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · Florida: Sarasota
• A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer
  NCT06764485 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · Florida: Lakeland
• A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
  NCT06440005 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Florida: Sarasota
• A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors
  NCT07181473 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Florida: Orlando
• A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
  NCT07540572 · Phase: Phase 1 · Ages: 18 Years to 99 Years · Sex: All (male and female) · Florida: Plantation
• A Study to Learn How Safe AZD6621 is, How Well it Works, and How it Moves Throughout the Body Over Time, in Adult Male Participants With Metastatic Prostate Cancer
  NCT07192614 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: Male · Florida: Orlando, Tampa
• A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
  NCT03972657 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Florida: Jacksonville, Tampa
• A Trial to Learn How Safe AZD9750 is and How Well it Works in People With Metastatic Prostate Cancer When Given With or Without Other Anticancer Drugs
  NCT07336446 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: Male · Florida: Tampa
• AVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad Onc
  NCT05351424 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Florida: Miami Beach
• AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
  NCT07611110 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · Florida: Miami
• Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
  NCT05422911 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · Florida: Tampa
• Accuracy of 18F-rhPSMA-7.3 PET/ MRI for Prediction of Lymph Node Metastasis in Localized High-Risk Prostate Cancer
  NCT06389786 · Phase: Not applicable (e.g. observational or device study) · Ages: 30 Years to 85 Years · Sex: Male · Florida: Jacksonville
• An Open-label Dose Escalation and Expansion, Followed by a Phase II Study of Tulmimetostat (DZR123) and JSB462 (Luxdegalutamide) in Patients With Progressive Metastatic Castrate Resistant Prostate Cancer (mCRPC) (TulmiSTAR-01)
  NCT07206056 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: Male · Florida: Jacksonville
• An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
  NCT05939414 · Phase: Phase 3 · Ages: 18 Years to 100 Years · Sex: Male · Florida: Jacksonville, Pensacola
• Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection
  NCT05413850 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: Male · Florida: Miami
• Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT
  NCT07455903 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · Florida: Miami
• At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
  NCT05969860 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Florida: Jacksonville
• Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types
  NCT05000294 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 99 Years · Sex: All (male and female) · Florida: Gainesville
• Autologous Gamma Delta T Cells to Target Prostate Stem Cell Antigen in mCRPC
  NCT06193486 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · Florida: Tampa
• Building Community Living Labs in Black Communities to Advance Prostate Health Equity and Reduce Prostate Cancer Disparities in Black Men
  NCT06541210 · Phase: Not applicable (e.g. observational or device study) · Ages: 21 Years to 80 Years · Sex: All (male and female) · Florida: Jacksonville
• Building on Trust: Navigating Preventive Lung, Breast, and Prostate Cancer Screenings at Community Resource Spots
  NCT07231159 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Florida: Orlando
• Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
  NCT04038502 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · Florida: Bay Pines, Orlando
• Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
  NCT05334069 · Phase: Not specified · Ages: 40 Years to 75 Years · Sex: All (male and female) · Florida: Aventura, Bonita Springs, Clearwater, Deerfield Beach
• Collection and Measurement of Biomarkers in Prostate Cancer Radiotherapy Patients
  NCT02997709 · Phase: Not specified · Ages: 30 Years and older · Sex: Male · Florida: Miami
• Comprehensive Outcomes for After Cancer Health
  NCT05349227 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Florida: Gainesville
• Customized TULSA-PRO Ablation Registry
  NCT05001477 · Phase: Not specified · Ages: 18 Years and older · Sex: Male · Florida: Jacksonville
• DESTINY-PANTUMOUR04
  NCT07124000 · Phase: Not specified · Ages: 18 Years to 130 Years · Sex: All (male and female) · Florida: Coral Springs, St. Petersburg, West Palm Beach
• Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
  NCT06592924 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · Florida: Aventura, Coral Gables, Coral Springs, Deerfield Beach
• Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
  NCT06239194 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Florida: Miami
• Dual BET and CBP/p300 Inhibitor in Patients With Targeted Advanced Solid Tumors and Hematological Malignancies
  NCT05488548 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Florida: Jacksonville
• Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
  NCT05983432 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Florida: Miami, Orlando, Port Saint Lucie
• Evaluating In Home Cancer Therapy Versus In Clinic Cancer Therapy in Black Men With Locally Advanced, Biochemically Recurrent and Metastatic Prostate Cancer
  NCT07073794 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · Florida: Jacksonville
• Exploring the Potential of Robotic Telesurgery in Remote Settings
  NCT07130708 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 90 Years · Sex: Male · Florida: Celebration
• FOG-001 in Locally Advanced or Metastatic Solid Tumors
  NCT05919264 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Florida: Jacksonville, Lake Mary
• Feasibility and Effect of Wrapping Nerves With a Multi-Layer Perinatal Tissue Allograft During Prostatectomy
  NCT06940271 · Phase: Not applicable (e.g. observational or device study) · Ages: 45 Years and older · Sex: Male · Florida: Jacksonville
• Feasibility of Patient-Centered Home Care (PCHC) to Reduce Disparities in High-Risk Black Men (BM) With Prostate Cancer (CaP)
  NCT06470750 · Phase: Not specified · Ages: 18 Years and older · Sex: Male · Florida: Jacksonville
• First-in-Human Study to Evaluate AZD8359 STEAP2 TCE in Participants With Prostate Cancer
  NCT07529717 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 100 Years · Sex: Male · Florida: Orlando
• High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
  NCT05011383 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · Florida: Gainesville, Orlando
• High Intensity Focused Ultrasound in Prostate Cancer
  NCT06402357 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · Florida: Gainesville
• Immunological Effects of Vitamin D Replacement Among Black/African American Prostate Cancer Patients
  NCT05045066 · Phase: Early Phase 1 · Ages: 18 Years and older · Sex: Male · Florida: Jacksonville
• Integrated Cancer Repository for Cancer Research
  NCT02012699 · Phase: Not specified · Ages: 19 Years to 110 Years · Sex: All (male and female) · Florida: Daytona Beach, DeLand, Orange City, Palm Coast
• International Registry for Men With Advanced Prostate Cancer (IRONMAN)
  NCT03151629 · Phase: Not specified · Ages: 21 Years and older · Sex: Male · Florida: Gainesville, Jacksonville, Tampa
• Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
  NCT05803941 · Phase: Phase 4 · Ages: 18 Years to 100 Years · Sex: Male · Florida: Jacksonville
• MRI/Ultrasound Fusion Guided Laser Ablation of Prostate Cancer
  NCT05241236 · Phase: Not specified · Ages: 50 Years and older · Sex: Male · Florida: Miami Lakes
• MRI/Ultrasound Fusion Guided Prostate Cryotherapy
  NCT02381990 · Phase: Not specified · Ages: 55 Years and older · Sex: Male · Florida: Miami Lakes
• Metabolic Impact and Compliance of Controlled, Varying, Mediterranean Diets in Pre-Surgical Prostate Cancer Populations (PROVISIONS)
  NCT06487507 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: Male · Florida: Miami
• Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T
  NCT06134232 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · Florida: Daytona Beach, Largo, Ocala, Riverview
• Neoadjuvant Darolutamide and Relugolix Combination Preceding Radical Prostatectomy for Prostate Cancer
  NCT06631521 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · Florida: Orlando
• Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
  NCT06780670 · Phase: Phase 2, Phase 3 · Ages: 18 Years to 100 Years · Sex: Male · Florida: Orlando
• PET Scan Study to Detect Prostate Cancer in Patients with Early PSA Recurrence
  NCT06617481 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · Florida: Orlando
• POSLUMA® (18F-rhPSMA-7.3) PET-CT for PIRADS 2/3 Lesions
  NCT07220720 · Phase: Phase 2 · Ages: 18 Years to 100 Years · Sex: Male · Florida: Jacksonville
• PSMA PET Combined With MRI for the Detection of PCa
  NCT07052214 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · Florida: Boca Raton, Miami
• PSMA-Directed Para-Aortic Radiation Therapy for Oligorecurrent Prostate Cancer
  NCT06392295 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · Florida: Miami
• PSMA-PET Imaging for Detecting Early Metastatic Prostate Cancer in Men w/ High Decipher Test Scores
  NCT03495427 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: Male · Florida: Tampa
• Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
  NCT06801236 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · Florida: Tampa
• Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors
  NCT06784193 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Florida: Sarasota
• Phase 2a Study of High-Dose Testosterone Followed by Radioligand Therapy in mCRPC
  NCT07476001 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · Florida: Tampa
• Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
  NCT07424547 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Florida: Plantation
• Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
  NCT07590934 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 99 Years · Sex: Male · Florida: Miami, Tampa
• Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
  NCT06056830 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · Florida: Jacksonville, Miami
• Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
  NCT00969111 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male · Florida: Jacksonville
• Precise Oncology Interventions in Nutrition and Training (OnPoint)
  NCT06534918 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Florida: Miami
• RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT
  NCT01885299 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · Florida: Miami
• Radiation Therapy With RapidPlan Knowledge-based Planning vs Human-Driven Planning for Treatment of Prostate Cancer
  NCT06625034 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · Florida: Jacksonville
• SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
  NCT03452774 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · Florida: Jacksonville, Miami, Tampa
• Sacral Neuromodulation for Male Overactive Bladder (MOAB)
  NCT06511141 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male · Florida: Miami, Orlando, Oxford